Pressure
BioSciences
New
Eco-Friendly
Agrochem
Subsidiary
Receives
Over $1,000,000 in Orders in First
Month
of Operations
PBI Agrochem Integration into the Sales
Channels of Its Planned
Asset Acquisition of a Global, Environmentally Responsible
Agrochem Company is Expected
to Result in a Significant Q3 2021 Impact
South Easton, MA --
August 12, 2021 -- InvestorsHub NewsWire
-- Pressure
BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the
development and sale of broadly enabling, pressure-based
instruments, consumables, and platform technology solutions
to the
worldwide
biotechnology,
biotherapeutics, nutraceuticals,
cosmetics,
agriculture, and
food
&
beverage
industries, today
announced that its
newly-formed agrochemicals
subsidiary
-
PBI
Agrochem, Inc. - has received initial
purchase orders for over $1M of eco-friendly
agrochemical products for delivery in 2021. Just three weeks
ago, the Company
announced
the
formation of its new agrochemicals
division in
anticipation of the
planned
asset
acquisition
of
a
global
agrochemicals products business focused on organically natural
and environmentally
responsible
products.
PBI's
President and CEO Richard T.
Schumacher
explained the fast development of early sales: "With integration
planning for this acquisition well underway, PBI
Agrochem
placed
an
initial
order for
specialized, proprietary bulk material in July
and began
establishing U.S. warehousing, processing,
and
final
product
packaging facilities. Our objective was to insert PBI
Agrochem
into
the supply chain
and sales channels of our
acquisition target, in order
to
capture early sales revenues that we
believe could
have an
immediate, accretive impact upon
PBI's overall operating results. These efforts
have
resulted in over $1M in
2021
customer
orders for eco-friendly
and
effective agrochemical
pest
control and
growth
stimulant products."
Mr.
Schumacher
continued: "We anticipate
that
the delivery and booking
for most of these orders will occur during the third quarter
2021. PBI investors
who
have
followed and supported the Company through recent years
understand
that this new incremental
revenue from PBI Agrochem represents a
potential
doubling
(or
more) of
quarterly
revenues,
when
added to sales of PBI's existing
core
products
and
services. With additional
orders expected to arrive over the coming weeks
and months, we
believe
Q4
2021
could substantially
exceed the results of
Q3
2021.
Our
new agrochem sales are
expected to accelerate PBI's rapidly improving growth
trajectory and
should
contribute
substantially towards our planned
transition
to
profitability
by the
end of 2022."
Mr. John
B. Hollister, Director of Sales and Marketing at PBI, said:
"The market potential
in agrochemicals is
enormous,
driven by the intersection of burgeoning global population growth
and accelerating environmental consciousness and priorities. Our
positioning in organically natural and ecofriendly product
solutions places PBI squarely within the hottest growth generation
in this sector.
Closing
on over $1M of orders
in
the
first
month of PBI Agrochem operations is a
welcome
signpost on the road
to major
growth and
profitability for
our
agrochem
operations.
The
broad array
of
eco-friendly products being integrated into
PBI will address a diversity of agrochem client needs throughout the
year, from
fertilizing
young
plants, to
mitigating
microbial and larger animal threats,
to
enhancing
the
appearance and
appeal of
finished
produce."
PBI's
Board Chairman Jeffrey N. Peterson commented on the synergies
achieved in PBI's move into agrochemicals: "The creation of many
organically natural and effective, environmentally-friendly
agrochemical products is typically achieved through utilization of
essential oil active ingredients extracted from plants, such as the
already popular use of orange peel essential oil in ant sprays.
PBI's breakthrough
Ultra
Shear Technology™ (UST™) platform, for creation of extremely
low-droplet size nanoemulsions of oils in water, offers
added
value for
a new
generation of
products
with improved
effectiveness and economics,
allowing less active material to deliver higher effectiveness when
applied or consumed. We are aggressively driving the creation
of pioneering partnerships around UST in application sectors from
pharmaceuticals to nutraceuticals to food/beverage
and many
more areas, as PBI's core strategy for growth and profitability. We
have singled out agrochemicals for a more aggressive forward
integration into an applications sector for UST, in a bid to
accelerate the cycle of education, trial, market demonstration,
product differentiation, and uniquely advantaged growth. We
are delighted to be sharing these insights into PBI's expected
accelerating growth trajectory and path to profitability with our
loyal investor base."
The asset
acquisition is subject to
certain
conditions, including the completion of all due diligence and
acquisition financing.
About
Pressure
BioSciences,
Inc.
Pressure
BioSciences,
Inc.
(OTCQB:
PBIO)
is
a
leader
in
the
development
and
sale
of
innovative,
broadly
enabling,
pressure-based
solutions
for
the
worldwide
life
sciences
and
other
industries.
Our
products
are
based
on
the
unique
properties
of
both
constant
(i.e.,
static)
and
alternating
(i.e.,
pressure
cycling
technology,
or
PCT)
hydrostatic
pressure.
PCT
is a
patented
enabling
technology
platform
that
uses
alternating
cycles
of hydrostatic
pressure
between
ambient
and
ultra-high
levels
to control
bio-molecular
interactions
safely
and
reproducibly
(e.g.,
cell
lysis,
biomolecule
extraction).
Our
primary
focus
is
in
the
development
of PCT-based
products
for
biomarker
and
target
discovery,
drug
design
and
development,
biotherapeutics
characterization
and
quality
control,
soil
&
plant
biology,
forensics,
and
counter-bioterror
applications.
Additionally,
major
new
market
opportunities
have
emerged
in
the
use
of
our
pressure-based
technologies
in
the
following
areas:
(1)
the
use
of our
recently
acquired,
patented
technology
from
BaroFold,
Inc.
(the
"BaroFold"
technology)
to
allow
entry
into
the
bio-pharma
contract
services
sector,
and
(2)
the
use
of our
recently-patented,
scalable,
high-efficiency,
pressure-based
Ultra
Shear
Technology
("UST")
platform
to
(i)
create
stable
nanoemulsions
of otherwise
immiscible
fluids
(e.g.,
oils
and
water)
and
to
(ii)
prepare
higher
quality,
homogenized,
extended
shelf-life
or room
temperature
stable
low-acid
liquid
foods
that
cannot
be
effectively
preserved
using
existing
non-thermal
technologies.
Forward
Looking
Statements
This
press
release
contains
forward-looking
statements.
These
statements
relate
to future
events
or
our
future
financial
performance
and
involve
known
and
unknown
risks,
uncertainties
and
other
factors
that
may
cause
our
or
our
industry's
actual
results,
levels
of
activity,
performance,
or
achievements
to
be
materially
different
from
any
future
results,
levels
of activity,
performance
or
achievements
expressed,
implied,
or inferred
by these
forward-looking
statements.
In some
cases,
you can
identify
forward-looking
statements
by
terminology
such
as
"may,"
"will,"
"should,"
"could,"
"would,"
"expects,"
"plans,"
"intends,"
"anticipates,"
"believes,"
estimates,"
"predicts,"
"projects,"
"potential"
or "continue"
or the
negative
of
such
terms
and
other
comparable
terminology.
These
statements
are
only
predictions
based
on
our
current
expectations
and projections
about
future
events.
You
should
not
place
undue
reliance
on
these
statements.
In evaluating
these
statements,
you
should
specifically
consider
various
factors.
Actual
events
or results
may
differ
materially.
These
and
other
factors
may cause
our actual
results
to
differ
materially
from
any
forward-looking
statement.
These
risks,
uncertainties,
and
other
factors
include,
but
are
not
limited
to,
the
risks
and
uncertainties
discussed
under
the
heading
"Risk
Factors"
in
the
Company's
Annual
Report
on
Form
10-K
for
the
year
ended
December
31,
2020, and
other
reports
filed
by
the
Company
from
time
to
time
with
the
SEC.
The
Company
undertakes
no
obligation
to
update
any
of the
information
included
in this
release,
except
as
otherwise
required
by law.
For
more
information
about
PBI
and
this
press
release,
please
click
on
the following
website
link:
http://www.pressurebiosciences.com
Please
visit
us
on
Facebook,
LinkedIn,
and
Twitter.
Pressure Biosciences (QB) (USOTC:PBIO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pressure Biosciences (QB) (USOTC:PBIO)
Historical Stock Chart
From Apr 2023 to Apr 2024